Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

NCT03211351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2018-02-26

No results posted yet for this study

Summary

With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte application on the lipid and stability of the tear film in dry eye patients

Conditions

  • Dry Eye
  • Tear Film
  • Lipid Layer
  • Liposic
  • Tears Naturale Forte

Interventions

DRUG

Liposic

one eye of the participant recieved Lipoic

DRUG

Tears Naturale Forte

the other eye of the participant recieved Tears Naturale Forte

Sponsors & Collaborators

  • Huaxia Eye Hospital Group

    lead OTHER

Principal Investigators

  • Chi Zhang, MD.PhD · Huaxia Eye Hospital of Foshan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-12-01
Completion
2018-01-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211351 on ClinicalTrials.gov